In practice:
The agenda will be built considering case studies and (project/regulatory) experience from the EBF community and presentations from a call for abstract (deadline for abstract submission: 31 May 2024).
Meeting attendance will be limited to 70 delegates.
More detail on the meeting can be found here
-
- Case studies on approaches and types of assays used to characterize vaccine immunogenicity.
- Scientific approaches applied to validation of vaccine immunogenicity assays for different therapeutic modalities.
- Experiences/feedback from regulatory agency on assays used to evaluate vaccine immunogenicity.
The meeting will be held at the NH Málaga, Spain
For your travel planning, the meeting will start at 10:00 CET on September 12th and will end around 16:00 CET on September 13th
We will negotiate conference rates with the NH hotel. Once available, the reservation link will be placed here.
All delegates will need to make their own hotel reservations. Hotel reservations are independent from the EBF.
To register for the meeting use this link
Registration includes entrance to the meeting, lunches/coffee breaks.
The registration fee = 580 Euro. There will be no early bird rate nor 1-day passes.
For maximum interaction, the meeting attendance is capped to 70 delegates (excluding presenters, for which the registration fee will be waived)
Cancellation policy:
Cancellation needs to be done 14 days before the meeting start date.Payment of the full conference fee will be required if cancelled after that date or on “no-show”.